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A B S T R A C T   
Background: In December 2013, it was discovered that drinking water supplied to one third of the households in 
Ronneby, southern Sweden, was highly contaminated by PFAS (sum level >10,000 ng/L) originated from fire-
fighting foams used at a nearby military airport. 
Objectives: To report serum PFAS levels of Ronneby residents participating in a biomonitoring program, and to 
describe the variation by age, sex and calendar period for residential exposure. In addition, a reference group 
living in a neighboring municipality without PFAS contaminated drinking water was examined. 
Methods: Blood samples and demographic data were collected for 3297 Ronneby residents and 226 individuals 
from the reference group. Yearly residence addresses were available for 3086 Ronneby residents from the na-
tional population registry. Serum concentrations of PFHxS, PFOS and PFOA were determined in all participants, 
with additional PFHpA, PFNA and PFDA in subsets of the participants. 
Results: The population geometric means for serum PFHxS, PFOS and PFOA were 114, 135 and 6.8 ng/mL for all 
Ronneby residents, i.e.135, 35 and 4.5 times higher than for the reference group. Ronneby residents who resided 
in the area with contaminated water supply during 2005–2013 showed much higher PFAS levels in 2014 than 
those exposed only before 2005. Ronneby residents who never resided in the area with contaminated water 
supply also had higher serum PFAS levels than the reference group. All three PFAS were highly correlated (rs >
0.9 for each pair). Serum PFAS levels were lowest in teenage years and then increased with age. Adult females 
had lower PFAS levels on average than males under the age of 60 but higher above 60. 
Discussion: The results reveal high serum PFAS levels dominated by PFHxS and PFOS in the Ronneby residents 
highly exposed to PFAS originated from firefighting foams. The PFAS exposure in Ronneby permits studies of 
associations to a range of health parameters, as well as studies of the toxicokinetics of PFAS exposure.   
1. Introduction 
Per- and polyfluoroalkyl substances (PFAS) are a group of thousands 
of synthetic chemicals that have been used since the early 1950s (Buck 
et al., 2011). Their structure with a fluorinated carbon chain of varying 
length and functional groups make them highly stable and thermally 
resistant. Because of their stability and water, dirt and grease-resistant 
properties they have been widely used in a multitude of technical ap-
plications and are now ubiquitous in the environment. Generally, 
humans are exposed to PFAS through diet, indoor air and dust (Begley 
et al., 2005; Berger et al., 2009; Falandysz et al., 2006; Shoeib et al., 
2005). In areas with PFAS point-source contamination, the exposure 
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from contaminated drinking water is of major importance (Domingo and 
Nadal, 2019). It was recently found that drinking water with PFAS well 
below current guidelines contributes to elevated PFAS levels in the 
general population (Glynn et al., 2020). 
International biomonitoring programs and cross-sectional studies 
show that general populations have detectable levels of PFAS in serum 
worldwide (Buck et al., 2011; Houde et al., 2006; Ingelido et al., 2018). 
The widespread PFAS contamination, together with the bio- 
accumulation properties and long half-lives of these substances, and 
experimental data on toxicity have raised concerns of environmental 
and human adverse effects. The first drinking water guidelines were 
issued in Germany, 2006 (Drinking Water Commission, 2006); since 
then many countries have followed. In Sweden, first action limits for 
PFAS in drinking water was issued in 2014, with levels of 90 ng/L for 
sum of seven PFAS [perfluoropentanoic acid (PFPeA), per-
fluorohexanoic acid (PFHxA), perfluoroheptanoic acid (PFHpA), per-
fluorooctanoic acid (PFOA), perfluorobutane sulfonic acid (PFBS), 
perfluorohexane sulfonic acid (PFHxS) and perfluorooctane sulfonic 
acid (PFOS); Livsmedelsverket, 2014]. 
In December 2013, before any action limits had been issued in 
Sweden, it was unexpectedly discovered that one out of two municipal 
waterworks in Ronneby, southern Sweden, had a sum of PFAS level 
above 10,000 ng/L in the outgoing drinking water (Table 1). The 
contaminated waterworks was closed on December 16, 2013, immedi-
ately after the exposure was discovered, and clean water was distributed 
from the other municipal waterworks. 
The PFAS exposure in Ronneby is thus a “natural experiment”, where 
a segment of the population had long-term exposure to PFAS from 
drinking water without knowing it, and with an abrupt end of exposure. 
In this paper, we report serum PFAS levels in the Ronneby residents who 
participated in a biomonitoring program, and in a reference group from 
a neighboring municipality with uncontaminated drinking water supply. 
We also describe how serum levels varied by age, sex and calendar 
period for residential exposure. 
2. Material and methods 
2.1. Study area 
Ronneby is a municipality with approximately 28,000 inhabitants in 
2013. Two waterworks (Brantafors and Kärragåden) provided drinking 
water to the whole municipality. In September 2013, sampling in a 
glaciofluvial water reservoir indicated PFAS contamination in the 
groundwater. From then on to December 2013, repeated water sam-
plings were performed, confirming very high PFAS levels in both the 
aquifer and the wells of one of the two waterworks in Ronneby (Bran-
tafors). No measurements before 2013 exist. 
The PFAS contaminated waterworks (Brantafors) distributed drink-
ing water to approximately one third of the households in Ronneby 
(Fig. 1). The source of the contamination was confirmed to be AFFF 
firefighting foams used at a nearby military airport, situated approxi-
mately 2 km from the waterworks wells. Information from the airport 
indicated that the use of AFFF foams started in the mid-1980s. No in-
formation was available on the formulations in the foams or changes 
over time. 
Table 1 shows the PFAS levels in the drinking water sampled at the 
two Ronneby waterworks on December 10 (i.e. the very last water 
sampling before the contaminated waterworks was closed). The 
contaminated waterworks had very high levels of multiple PFAS in the 
outgoing drinking water with sum of PFAS above 10,000 ng/L. The 
other waterworks, from which water was redirected to the contaminated 
waterworks district from December 16, had sum of PFAS below the 
action limits, 90 ng/L, but still higher than the waterworks in the 
neighboring municipality, Karlshamn. Private wells in the vicinity of the 
airport were also investigated, with some contamination but no in-
dications of elevated PFAS levels above the action limits. 
2.2. Study population 
In February 2014, i.e. two months after provision of clean water, we 
performed a pilot study including 11-year-old children from a school in 
the area with previous contaminated drinking water supply (n = 20) and 
from a school in the area supplied from the other waterworks (n = 17). 
High serum levels of PFAS in the 20 children who had been exposed to 
contaminated drinking water (Table S1) were found, which prompted 
extensive population biomonitoring in the municipality. 
The biomonitoring started in June 2014, i.e. six months after pro-
vision of clean water. All residents in the municipality were invited to 
free-of-charge blood samplings. Information on the samplings was 
repeatedly given through local media, the municipality website, an-
nouncements in libraries and the town hall, and through schools and 
workplaces. Over 20 sampling occasions were arranged between June 
2014 and December 2015 to recruit as many participants as possible. 
Inhabitants living in the area with drinking water supplied by the 
minimally contaminated waterworks were explicitly invited. In total 
there were 3507 participants, about 13% of the entire Ronneby popu-
lation at the time. The participation rates from contaminated and 
minimally contaminated areas were approximately 30% and 5%, 
respectively. All participants received written information about their 
serum PFOS, PFHxS and PFOA levels. Informed consent for participation 
in further studies and biobanking of serum samples was given by 3297 
(94%) of participants (aged 0–92 years). Thus, this open sampling is the 
Table 1 
PFAS levels in drinking water from contaminated waterworks (Brantafors), 
minimally contaminated waterworks (Kärragården), and from the main water-













PFPeA 38 10 <0.6 
PFHxA 320 3.6 <0.3 
PFHpA 32 1.4 <0.3 
PFOA 100 1.0 <0.3 
PFNA <1 <1 <0.6 
PFDA <1 <1 <0.6 
PFUnDA <10 <10 <2 
PFDoDA <10 <10 <2 
PFBS 130 <2.6 <0.3 
PFHxS 1700 4.6 <0.3 
PFHpS 60 <1 <0.3 
PFOS 8000 27 <0.2 
Sum of 
PFAS d 
10,380 47.6 <5 
Note: PFAS, perfluoroalkyl substances; PFPeA, perfluoropentanoic acid; PFHxA, 
perfluorohexanoic acid; PFHpA, perfluoroheptanoic acid; PFOA, per-
fluorooctanoic acid; PFNA, perfluorononanoic acid; PFDA, perfluorodecanoic 
acid; PFUnDA, perfluoroundecanoic acid; PFDoDA, perfluorododecanoic acid; 
PFBS, perfluorobutane sulfonic acid; PFHxS, perfluorohexane sulfonic acid; 
PFHpS, perfluoroheptane sulfonic acid; PFOS, perfluorooctane sulfonic acid. 
a Multiple water samplings were performed. Here lists the data from water 
sampled on December 10th 2013, the very last sampling before the contami-
nated waterworks was closed. 
b Water sampled on January 15th 2020 
c PFAS analysis in drinking water was performed by a commercial water 
analysis company, SYNLAB (SYNLAB Analytics & Services Sweden AB, Link-
öping, Sweden), according to German standard methods for determination of 
selected polyfluorinated compounds in water using liquid chromatography- 
tandem mass spectrometry (LC/MS/MS) after solid-liquid extraction (F 42) 
(DIN 38407-42). SYNLAB is accredited by SWEDAC according SS-EN ISO/IEC 
17025. 
d Sum of all PFAS with levels above LOD for waterworks in Ronneby. For 
Karlshamn, the sum of PFAS was reported by the water analysis company. 
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baseline investigation for the Ronneby Biomarker Cohort. Information on 
smoking history, self-reported water and fish intake, pregnancy and 
breast feeding, firefighting experience, and addresses of daycare, school 
and work from 1985 and on were obtained from a short questionnaire. 
Height and weight were self-reported, with the possibility to measure 
height and weight at the sampling site. In addition, we retrieved yearly 
residential and workplace addresses during 1980–2013 from the Total 
Population Register (Statistics Sweden, www.scb.se) for 3086 partici-
pants. The address data were linked to detailed municipal lists of water 
supply. 
The Ronneby Biomarker Cohort includes not only residents living in 
the areas with heavily contaminated drinking water but also those living 
in parts of Ronneby supplied by minimally contaminated waterworks. 
The latter ones were likely, to a varying extent, to drink contaminated 
water at work, at school, or during visits in the areas supplied by the 
contaminated waterworks. Therefore, in 2016, we also recruited 226 
individuals (aged 5–59 years) from a neighboring municipality, Karl-
shamn, with PFAS-uncontaminated drinking water supply, as a refer-
ence group. Drinking water in Karlshamn had all PFAS levels below limit 
of detection (Table 1). 
Fig. 2 illustrates the composition of the Ronneby Biomarker Cohort 
and its reference group. The study was approved by the Regional Ethical 
Review Board in Lund, Sweden (approved, date: 2014-04-22, approval 
number: 2014/4). 
Fig. 1. The left map shows the location of Ronneby municipality in Sweden. The right map of Ronneby municipality shows the district with PFAS-contaminated 
drinking water supply in 2013 (area within solid black lines with gray gradient), together with the locations of the military airport, the contaminated water-
works Brantafors and the uncontaminated waterworks Kärragården. Background map data: © OpenStreetMap contributors, CC BY-SA. 
Fig. 2. The illustration of the Ronneby Biomarker Cohort and its reference group.  
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2.3. Serum PFAS analysis 
Venous blood was collected in 5 ml Becton Dickinson vacutainer 
blood collection tubes (BD, Belliver Industrial Estate, Plymouth, UK) 
without gel. When venous blood sampling could not be performed 
(mainly for very small children), capillary sampling was performed. The 
blood samples were left in room temperature for at least 30 min before 
being centrifuged, then, serum was immediately transferred to storage 
tubes, transported on dry ice to the laboratory at Occupational and 
Environmental Medicine, Lund University, Lund, Sweden, and frozen at 
− 80 ◦C (Lindh et al., 2012). 
In the pilot study with 37 children, 15 different PFAS: PFBS, PFHxS, 
PFOS, perfluorodecane sulfonic acid (PFDS), as well as PFHxA, PFHpA, 
PFOA, perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), 
perfluoroundecanoic acid (PFUnDA), perfluorododecanoic acid 
(PFDoDA), perfluorotridecanoic acid (PFTrDA), perfluorotetradecanoic 
acid (PFTeDA), perfluorohexadecanoic acid (PFHxDA) and per-
fluorooctadecanoic acid (PFODA) were quantitated. The low levels 
found for PFAS with longer carbon chain (Table S1) led to selection of a 
limited set of compounds for quantitation in the main study. In the first 
901 samples obtained in June 2014 from the Ronneby Biomarker Cohort, 
six PFAS: PFHxS, PFOS, PFHpA, PFOA, PFNA and PFDA were selected to 
be quantitated (Table S2). The results showed that the levels of PFHxS, 
PFOS and PFOA were much higher than the other three PFAS in serum, 
therefore, only PFHxS, PFOS and PFOA were decided to be quantitated 
for all study participants (N = 3523, 3297 Ronneby Biomarker Cohort 
participants and 226 reference group) due to practical reason. PFHpA, 
PFNA and PFDA were also quantitated in 51 samples randomly selected 
from the reference group (sampled in October 2016) for comparison 
purpose. 
PFHxS, PFOS and PFOA were determined as the total, non-isomer 
specific compounds according to the method described by Lindh et al. 
(2012) and Li et al. (2018). Briefly, after thawing and vortexing samples, 
the proteins were precipitated using acetonitrile by vigorous shaking for 
30 min. The samples were then centrifuged, and an aliquot of the su-
pernatant was analyzed using liquid chromatography (LC) (UFLCXR, 
SHIMADZU Corporation, Kyoto, Japan) connected to tandem mass 
spectrometry (MS/MS) (QTRAP 5500 and 6500+, Sciex Framingham, 
MA, USA). Serum samples from populations expected to have high 
exposure to PFAS were prepared using diluted aliquots of 25 μl serum 
added with 75 μl of water and isotopically labeled internal standards for 
all compounds, and 1 µl of the samples were analyzed using LC/MS/MS. 
If lower levels were expected, aliquots of 100 μl serum were used and 4 
µl of the samples were analyzed. In all batches, chemical blanks and 
three quality control (QC) samples, prepared in-house from serum 
spiked with different PFAS were included. The limit of detection (LOD) 
and detection frequency of all PFAS reported in this paper are listed in 
Table 2. 
The analyses of PFOS and PFOA are part of a quality control pro-
gramme between analytical laboratories coordinated by Professor Hans 
Drexler, Institute and Outpatient Clinic for Occupational, Social and 
Environmental Medicine, University of Erlangen-Nuremberg, Germany. 
The laboratory also participated in the HBM4EU QA/QC programme, 
and its successful performance has resulted in its qualification as 
HBM4EU laboratory for the analysis of: PFPeA, PFHpA, PFOA, PFNA, 
PFDA, PFUnDA, PFDoDA, PFBS, PFHxS, PFHpS and PFOS. 
In addition to each PFAS, we also calculated the sum of three PFAS 
on weight basis for all study participants, and sum of four PFAS (i.e. 
PFOS, PFHxS, PFOA and PFNA) for participants with quantitated PFNA. 
Reporting sum of PFAS is scientifically sound and reasonable for regu-
latory purpose to protect our health and environment now and in the 
future (Kwiatkowski et al., 2020). In the recent report, EFSA assessed 
and set PFAS tolerable weekly intake as 4.4 ng/kg bw per week based on 
sum of four PFAS and called for reporting results for the sum of several 
PFAS for risk assessment (EFSA, 2020). 
2.4. Drinking water exposure groups, based on address data 
For the participants from Ronneby, we assessed the historical resi-
dential exposure based on information on registered yearly residence 
addresses. We linked all addresses to data on yearly water supply ob-
tained from the municipality water company. Thus, we were able to 
identify, for each calendar year, if the address was supplied with high or 
low PFAS concentrations in the drinking water. Based on source of 
drinking water at residency, we assigned Ronneby residents to mutually 
exclusive groups: never-high (i.e. always low), and ever-high, with the 
latter group further separated into early-high and late-high (Table 3). All 
residential addresses with private wells were assumed to have had low 
contamination. The reference group consists of all participants from 
Karlshamn. 
Residential addresses thus allowed a crude classification of the 
population by different potential for exposure to PFAS in drinking water. 
While we cannot know for sure when the contamination reached the 
water supply, we are confident that it was not prior to the mid-1980s 
when PFAS containing AFFF was first used. Moreover, we can safely 
assume that the levels in the contaminated aquifer rose over the sub-
sequent years, being highest in the last decade prior to its discovery, and 
had arrived at the waterworks wells prior to 2004, our tentative cut-off 
for early and late exposure. The early-high group had moved out of the 
contaminated water distribution district by 2004, thus allowing for a 10 
year elimination period, or even longer. 
2.5. Statistical analysis 
Study subjects were grouped into eight age strata by 10-year in-
tervals (i.e. 0–10, 11–20, 21–30, 31–40, 41–50, 51–60, 61–70 and >70 
years-old). For the reference group, only six age strata were available, up 
to age 60. For those in the early-high and late-high groups, total 
numbers of years of exposure was calculated as total years of residence 
in the area with contaminated water supply. Numbers of years since 
exposure stopped was calculated as elapsed years between end of 
exposure to contaminated water at residency (i.e. in 2013 when the 
Table 2 
List of PFAS, their corresponding acronyms, limit of detections (LOD), number of samples (n) and detection frequencies (df) in the Ronneby Biomarker Cohort and its 
reference group.    
Ronneby Biomarker Cohort Reference group 
Analyte a Acronym LOD (ng/mL) n df (%) LOD (ng/mL) n df (%) 
Perfluoroheptanoic acid PFHpA 0.05 901 56 0.02 51 73 
Perfluorooctanoic acid PFOA 0.4 3293 100 0.2 219 100 
Perfluorononanoic acid PFNA 0.05 901 100 0.08 51 100 
Perfluorodecanoic acid PFDA 0.09 901 89 0.04 51 100 
Perfluorohexane sulfonic acid PFHxS 0.5 3293 100 0.02 219 100 
Total Perfluorooctane sulfonic acid PFOS 0.5 3293 100 0.05 219 100  
a PFAS were analyzed with the original method used from June 2014 to 2018. Details of the original method were reported by Lindh et al. (2012), Li et al. (2018) and 
Glynn et al. 2020. 
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contaminated waterworks shut down, or year when moved out from the 
area with contaminated water supply) and blood sampling. PFAS levels 
were log-transformed in all regression models to improve the model fit. 
Since our study population had a very wide age range, a generalized 
additive model was used to produce smooth splines to visualize the non- 
linear relationship between serum PFAS levels and age (Wood, 2017). In 
the regression models that compare the serum PFAS levels between the 
Ronneby Biomarker cohort and the reference group, as well as across 
exposure groups, log-transformed PFAS levels were estimated as smooth 
functions (thin plate splines) of age and BMI, with sex as a covariate in 
the models. In the regression models comparing sex-specific serum PFAS 
levels in each age stratum, age and BMI were included as continuous 
variables. Spearman’s correlation coefficient was used for correlations 
between serum levels of pairs of each PFAS compound in the Ronneby 
Biomarker Cohort. Generalized additive model was performed in R using 
the ‘mgcv’ package. Linear regression and correlation analysis were 
performed using IBM SPSS 26.0 (IBM, Armonk, NY, USA). All p values 
were two-sided. 
3. Results 
3.1. Serum PFAS levels in the Ronneby Biomarker Cohort and its 
reference group 
Population summary statistics for PFHxS, PFOS, PFOA and sum of 
three PFAS from the Ronneby Biomarker Cohort and the reference group, 
stratified by sex and age groups are given in Table 4. The population 
geometric means (GM) were 114 ng/mL for PFHxS, 135 ng/mL for PFOS 
and 6.8 ng/mL for PFOA, which were 135, 35 and 4.5 times higher than 
the reference group. 
In the Ronneby Biomarker Cohort, the relations between PFHxS, 
PFOS, sum of three PFAS levels and age groups were J-shaped, with the 
age group 11–20 having lowest population GM of serum PFAS in both 
sexes. In the age groups between 20 and 50, females had clearly lower 
serum levels than males, in models adjusted for age and BMI. Above and 
below this age range the contrasts were small and confidences intervals 
were wide, although the results suggest that females had higher levels 
than males above age 60 (Table 5). Such pattern by age and sex was 
further highlighted using smooth splines (Fig. 3A) based on sum of three 
PFAS, showing that serum PFAS slightly decreased from childhood to 
teenage years and then increased with age. The difference between 
males and females in PFAS levels had a turn over point at around age 55. 
In the reference group, children aged 0–10 and 11–20 showed quite 
similar serum PFAS levels between sexes. From age 20 to 60, females 
constantly showed lower PFAS levels than males in all age groups 
(Table 5, Fig. 3B). 
Serum levels of PFHpA, PFNA and PFDA were only quantitated in the 
first 901 samples from Ronneby Biomarker Cohort, and 51 samples from 
the reference group (Table 6). The GM of PFHpA was on average 4.3 
(95%CI: 2.7, 6.9) times higher in the Ronneby participants than in the 
reference group. On the contrary, PFNA and PFDA were lower in the 
Ronneby participants [ratio 0.8 (95%CI: 0.7, 0.9) for PFNA, and 0.6 
(95%CI: 0.5, 0.8) for PFDA] adjusted for age, BMI and sex. Including 
PFNA into the sum of 4 PFAS only increased the GM of sum by 0.2% in 
the Ronneby participants. In the reference group, the inclusion of PFNA 
increased the GM of sum by 12%, compared to the sum of 3 PFAS. 
Serum levels of PFHxS, PFOS and PFOA were very highly correlated 
(Spearman’s rs > 0.9, p < 0.001 for all pairs) in the Ronneby Biomarker 
Cohort. The pairwise correlations to PFHpA, PFNA and PFDA were 
weaker and rs were generally around 0.2–0.4. The weakest correlations 
were found between PFHpA and PFDA or PFNA (Table 7). 
3.2. Serum PFAS levels in the drinking water exposure groups based on 
residential address 
The total numbers of years of exposure and years since exposure 
stopped are given in Table 2. The median number of years of exposure 
was 16 years for the late-high group, and 6 years for the early-high 
group. In the late-high group, the majority of participants (1937; 
87%) had contaminated drinking water at home until December 2013. 
Ronneby residents, no matter where they had resided, the serum 
PFAS levels exceeded the findings in the reference group (Table 8). The 
largest difference was observed for PFHxS, where the late-high group 
had a GM of 210 ng/mL, >190 times higher than the GM in reference 
group. Smaller but still substantial differences were also observed for 
PFOA, where the Ronneby participants (all three groups) had about 1.9 
to 7.3 time higher. 
Table 3 
Drinking water exposure groups, definition, counts and exposure characteristics 


















Late-high Resided in Ronneby, in 
the area with water 
supply from the highly 
contaminated 
waterworks at home 
address in 2005–2013, 
may also resided in 
same area in 
1985–2004 
2219 16 (2, 29) 1 (1, 6) 
Early-high Resided in Ronneby, in 
the area with water 
supply from the highly 
contaminated 
waterworks at home 
address in 1985–2004, 
but not later. 
283 6 (1, 18) 18 (11, 28) 
Ever-high Resided in Ronneby, in 
the area with water 
supply from the highly 
contaminated 
waterworks at home 
address any time in 
1985–2013 
2502 14 (2, 29) 1 (1, 19) 
Never-high Resided in Ronneby, 
but never resided in the 
area with water supply 
from the highly 
contaminated 
waterworks at the home 
address or had own well 
in 1985–2013 
582 – – 
Reference Resided in neighboring 
municipality, 
Karlshamn. Never 
resided in Ronneby 
during 1985 to 2013 
226 – –  
a Through linkage between registered yearly residence addresses and the data 
on yearly water supply area obtained from the municipality water company, we 
were able to identify, for each calendar year, if the address was supplied with 
contaminated or minimally contaminated drinking water. Then we assigned 
individuals to four exposure groups according to their historical residence 
addresses. 
b If someone moved out from the contaminated area in the early period and 
never moved in again, this person only contributes counts for the Early-high 
group. If one person moved out from the contaminated area in the early 
period and moved in again (e.g. moved out in 1990 and moved in again in 2010), 
this person only contributes counts for the Late-high group. 
c Total number of years of residence in the area with contaminated water 
supply. If a person has moved out and moved in again, the years in between were 
not summed up. 
d Total number of years between the last time a person moved out from the 
area with contaminated water supply and the time of sampling (i.e. 2014–2015). 
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4. Discussion 
The PFAS contaminated drinking water from a municipal water-
works led to globally unique serum levels in the local population, not 
only regarding the high concentrations but also concerning the 
composition of different PFAS, reflecting contamination from AFFF 
firefighting foam (Rotander et al., 2015). The dominating PFAS were 
PFHxS and PFOS, which led to population GM about 135 and 35 times 
higher in the Ronneby participants than a reference population with 
background exposure. In contrast, PFOA levels were 4.5 times higher 
than the reference population. 
The increasing awareness of widespread PFAS contaminated 
Table 4 
Geometric mean (GM), 5 and 95 percentiles of serum PFAS levels (ng/mL) in the Ronneby Biomarker Cohort and in the reference group, stratified by sex and age group.    
PFHxS PFOS PFOA Sum of 3 PFAS a  
Count GM P5 P95 GM P5 P95 GM P5 P95 GM P5 P95 
Ronneby Biomarker Cohort 3293 114 7.0 715 135 12 718 6.8 1.4 37 262 21 1465 
Female 1795 102 5.6 758 124 11 743 8.1 1.3 38 239 19 1539 
0–10 155 89 19 303 98 14 315 8.9 1.9 26 199 37 617 
11–20 162 54 5.5 249 70 6.9 291 5.2 1.3 19 131 13 559 
21–30 206 60 6.6 334 79 9.0 331 5.0 1.0 19 146 16 670 
31–40 257 61 5.6 357 82 9.7 421 5.1 1.0 22 150 18 783 
41–50 348 85 4.0 525 109 8.3 552 6.9 1.1 30 206 14 1105 
51–60 266 130 4.3 800 157 10 779 9.8 1.6 37 304 17 1631 
61–70 263 220 10 944 240 16 911 15 1.8 48 483 30 1810 
>70 138 341 21 1078 349 25 1053 20 2.7 55 716 49 2066 
Male 1497 129 9.5 658 149 15 698 9.6 1.9 37 292 27 1393 
0–10 183 103 18 324 113 18 362 10 2.5 28 230 34 700 
11–20 178 65 3.6 300 85 5.5 360 6.3 1.2 21 159 9.6 666 
21–30 138 110 14 395 133 22 440 8.2 2.3 24 255 41 825 
31–40 208 96 5.0 483 114 12 540 7.0 1.7 27 221 20 1060 
41–50 267 155 14 688 170 17 687 10 2.0 38 341 31 1412 
51–60 204 146 6.9 629 163 16 668 10 2.1 34 325 28 1429 
61–70 196 183 7.3 792 210 21 831 13 2.7 43 416 31 1653 
>70 123 299 24 932 330 32 1001 18 2.7 59 653 64 1956 
Reference Group 219 0.84 0.33 3.5 3.9 1.6 11 1.5 0.74 3.4 6.6 3.0 17 
Female 120 0.76 0.33 2.4 3.5 1.3 9.1 1.5 0.66 3.3 6.0 2.7 14 
0–10 37 0.57 0.31 2.3 3.0 1.2 6.2 1.5 0.90 2.9 5.2 3.0 9.2 
11–20 7 0.59 0.36 1.2 2.2 1.4 3.6 1.2 0.74 2.1 4.0 2.7 5.7 
21–30 21 0.89 0.33 2.7 3.2 1.2 6.0 1.4 0.66 3.2 5.8 2.3 10 
31–40 16 0.85 0.22 2.1 3.2 0.23 8.5 1.2 0.30 3.6 5.7 1.5 11 
41–50 16 0.87 0.41 3.6 4.4 2.1 13 1.6 0.65 4.4 7.1 4.0 20 
51–60 23 0.94 0.50 2.2 5.4 2.5 10 1.7 1.1 2.8 8.1 3.9 15 
Male 99 0.96 0.34 8.2 4.5 1.7 12 1.7 0.95 3.4 7.5 3.3 21 
0–10 35 0.48 0.33 0.9 3.0 1.3 6.3 1.6 1.2 2.7 5.2 3.0 9.0 
11–20 8 0.64 0.37 1.0 3.7 1.6 5.5 1.3 0.62 2.2 5.7 2.6 8.5 
21–30 16 1.2 0.61 8.0 4.8 2.0 9.1 1.8 0.95 4.2 8.0 3.9 18 
31–40 9 1.8 0.35 19 5.1 1.5 15 1.8 1.2 3.4 9.9 3.3 26 
41–50 19 1.4 0.32 12 5.7 1.9 13 1.5 0.79 3.1 9.0 3.2 26 
51–60 12 2.4 1.0 28 9.6 4.8 49 2.3 1.2 4.9 15 8.5 81 
Note: PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonic acid; PFOS, perfluorooctane sulfonic acid, PFOA, perfluorooctanoic acid; GM, geometric 
mean; P5 and P95, 5 and 95 percentiles. 
a Sum of concentrations of PFHxS, PFOS and PFOA. 
Table 5 
The ratios in serum PFAS levels (ng/mL) between sexes in each age strata of the Ronneby biomarker Cohort and reference group.   
PFHxS PFOS PFOA Sum of 3 PFAS 
Age group Ratio (95%CI) a,b P a Ratio (95%CI) a,b P a Ratio (95%CI) a,b P a Ratio (95%CI) a,b P a 
Ronneby Biomarker cohort 
0–10 0.86 (0.68, 1.08) 0.18 0.86 (0.69, 1.06) 0.15 0.88 (0.75, 1.04) 0.14 0.86 (0.70, 1.06) 0.16 
11–20 0.84 (0.62, 1.12) 0.24 0.82 (0.63, 1.09) 0.17 0.84 (0.69, 1.02) 0.08 0.83 (0.63, 1.09) 0.17 
21–30 0.55 (0.42, 0.72) <0.001 0.59 (0.47, 0.75) <0.001 0.61 (0.51, 0.74) <0.001 0.57 (0.45, 0.73) <0.001 
31–40 0.65 (0.51, 0.83) <0.001 0.73 (0.58, 0.91) 0.01 0.73 (0.61, 0.87) <0.001 0.69 (0.55, 0.87) <0.001 
41–50 0.55 (0.43, 0.69) <0.001 0.64 (0.52, 0.79) <0.001 0.68 (0.57, 0.80) <0.001 0.61 (0.49, 0.75) <0.001 
51–60 0.86 (0.66, 1.14) 0.29 0.95 (0.75, 1.19) 0.63 0.96 (0.79, 1.16) 0.66 0.91 (0.72, 1.17) 0.47 
61–70 1.21 (0.94, 1.57) 0.14 1.15 (0.92, 1.44) 0.21 1.12 (0.94, 1.33) 0.20 1.17 (0.93, 1.47) 0.18 
>70 1.19 (0.90, 1.56) 0.23 1.10 (0.85, 1.42) 0.48 1.15 (0.91, 1.45) 0.24 1.14 (0.88, 1.48) 0.33 
Reference group 
0–10 1.19 (0.93, 1.51) 0.16 1.00 (0.8, 1.26) 0.99 0.91 (0.79, 1.04) 0.16 0.99 (0.83, 1.19) 0.93 
11–20 1.00 (0.55, 1.81) 0.99 0.76 (0.42, 1.38) 0.33 1.19 (0.66, 2.12) 0.53 0.90 (0.53, 1.52) 0.66 
21–30 0.75 (0.48, 1.19) 0.21 0.68 (0.48, 0.96) 0.03 0.81 (0.55, 1.17) 0.25 0.73 (0.53, 1.00) 0.05 
31–40 0.30 (0.14, 0.67) 0.01 0.57 (0.25, 1.31) 0.18 0.77 (0.44, 1.35) 0.34 0.48 (0.25, 0.92) 0.03 
41–50 0.63 (0.37, 1.08) 0.09 0.76 (0.53, 1.10) 0.14 1.10 (0.80, 1.51) 0.55 0.80 (0.56, 1.13) 0.2 
51–60 0.40 (0.24, 0.64) <0.001 0.55 (0.38, 0.78) <0.001 0.73 (0.55, 0.97) 0.03 0.54 (0.38, 0.77) <0.001 
Note: PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonic acid; PFOS, perfluorooctane sulfonic acid, PFOA, perfluorooctanoic acid. 
a From linear regression model: ln_PFAS = a + β1*sex + β2*age + β3*BMI. Age and BMI were treated as continuous variable in the model. Ratio = exp(β1). 
b The ratio was females vs. males. For example: females had average 0.55 times lower serum PFHxS than males in age group 21–30 in the Ronneby Biomarker Cohort. 
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drinking water originated from AFFF has led to increase numbers of 
studies investigating such exposure. Many countries have launched 
nation-wide exposure assessments focusing on the communities near 
current or former military airbase. For instance, Agency for Toxic Sub-
stances and Disease Registry (ATSDR) together with the Centers for 
Disease Control and Prevention (CDC) initiated exposure assessments in 
eight US communities in 2018 (https://www.atsdr.cdc.gov/pfas/activiti 
es/assessments.html). In Sweden, water sampling and biomonitoring of 
residents have been performed in four municipalities (including Ron-
neby) with military or civil airports nearby (Jakobsson et al., 2019). 
However, the published studies on general population exposure after 
AFFF contamination is still scarce, as are reports of health effect (Gyl-
lenhammar et al., 2015; Daly et al., 2018; Barton et al., 2020; Nair et al., 
2020). The Ronneby exposure scenario, dominated by PFOS and PFHxS, 
differs from populations with PFOA-dominating exposure from indus-
trial sources (Frisbee et al., 2009; Hölzer et al., 2008; Ingelido et al., 
2018). The serum PFAS levels comparison between studies are sum-
marized in Table 9. 
PFAS with less than eight carbons in the chain length (e.g. PFPeA, 
PFHxA, PFHpA and PFBS, PFPeS, PFHpS) were present in the drinking 
water in Ronneby municipality. Correspondingly, serum PFHpA was 
found to be considerably higher in Ronneby participants than in the 
reference group, together with serum PFBS to be higher in the 20 stu-
dents living within exposed area than those living outside exposed area 
from the pilot study (Table S1). Notably, the serum levels of these 
shorter chain PFAS during exposure are underestimated due to the lag of 
two to six months between when the external exposure stopped and the 
first blood sampling, given their relatively faster elimination rate (Xu 
Fig. 3. Smooth spline of sum of 3 PFAS with 95% confidence intervals in (A) Ronneby Biomarker Cohort and (B) Reference group, stratified by age and sex in. The 
points on the graph are the original data. 
Table 6 
Geometric mean (GM), Median, 5 and 95 percentiles of serum concentrations (ng/mL) of PFHpA, PFOA, PFNA, PFDA, PFHxS and PFOS in first 952 samples obtained 
from Ronneby Biomarker Cohort and the reference group.  
PFAS Ronneby Biomarker Cohort (n = 901) Reference Group (n = 51)  
(ng/mL) GM P5 Median P95 GM P5 Median P95 Max Ratio (95%CI) c 
PFHpA 0.11 <LOD 0.06 0.8 0.04 0.01 0.04 0.2 0.20 4.3 (2.7, 6.9) 
PFOA 15 3.0 17 47 1.5 1.0 1.4 2.9 3.8 8.1 (6.5, 10) 
PFNA 0.67 0.3 0.7 1.8 0.50 0.3 0.5 1.0 1.3 0.8 (0.7, 0.9) 
PFDA 0.24 0.04 0.3 0.8 0.22 0.1 0.2 0.4 0.6 0.6 (0.5, 0.8) 
PFHxS 229 33 280 866 0.49 0.3 0.5 1.0 6.9 298 (220, 403) 
PFOS 262 42 303 874 3.0 1.2 2.9 6.2 13.1 57 (43, 75) 
Sum of three PFAS a 511 82 606 1770 5.1 3.0 4.8 9.0 22.9 65 (49, 86) 
Sum of four PFAS b 512 82 607 1771 5.7 3.3 5.3 9.8 24.2 59 (45, 78) 
Note: PFHpA, perfluoroheptanoic acid; PFOA, perfluorooctanoic acid; PFNA, perfluorononanoic acid; PFDA, perfluorodecanoic acid; PFHxS, perfluorohexane sulfonic 
acid; PFOS, perfluorooctane sulfonic acid. 
a Sum of concentrations of PFHxS, PFOS, PFOA. 
b Sum of concentrations of PFHxS, PFOS, PFOA and PFNA. 
c Ratio (95%CI) were from thin plate regression spline: ln_PFAS = a + β1*(Ronneby vs. reference) + β2*sex + β3*BMI + β4*age. Age and BMI were treated as smooth 
functions in the model. The ratio = exp (β1). 
Table 7 
Spearman’s correlation coefficients and p-values between each PFAS compound 
in the Ronneby Biomarker Cohort.   
PFOA a PFOS a PFHpA b PFNA b PFDA b 




























PFNA b     0.73 
(<0.001) 
Note: PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonic acid; 
PFOS, perfluorooctane sulfonic acid, PFOA, perfluorooctanoic acid; PFHpA, 
perfluoroheptanoic acid; PFNA, perfluorononanoic acid; PFDA, per-
fluorodecanoic acid. 
a Correlations were based on 3293 participants in the Ronneby Biomarker 
Cohort. 4 participants did not have quantitated PFAS in serum. 
b Correlations were based on 901 Ronneby participants with PFHpA, PFNA 
and PFDA quantitated in serum. 
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et al., 2020b). Approximately, in December 2013 the GM of serum 
PFHpA would have been 0.88 ng/mL, based on level measured in June 
2014 (GM = 0.11 ng/mL, Table 6) and mean observed half-life as 62 
days reported by Xu et al. (2020b). 
In a recent EFSA draft opinion on PFAS, PFNA was included, in 
addition to PFOS, PFHxS and PFOA for calculation of tolerable weekly 
intake (EFSA, 2020). In our reference group, where background expo-
sure levels were comparable or even slightly lower than the European 
general population summarized by EFSA and the US population reported 
by NHANES 2015–2016 (Table 9), we found that PFNA constituted 10% 
of the sum of four PFAS. In contrast, the contribution of PFNA to the sum 
of four PFAS in the Ronneby biomarker cohort was negligible. Similar 
findings of low levels of PFNA in serum, as well as in water samples, 
were observed around another two airports in Sweden (Xu et al., 2020b; 
Livsmedelsverket, 2017). Moreover, in two studies with US residents 
exposed to AFFF contaminated drinking water, PFNA was also detected 
in most of the serum samples, but showed a relatively lower concen-
trations (median = 0.4 ng/mL in Barton et al. (2020) and GM = 0.7 ng/ 
mL in Nair et al. (2020)) compared to PFHxS, PFOS and PFOA (Table 9), 
and such levels were comparable or even slightly lower than those re-
ported in the U.S. general population. Taken together, it is reasonable to 
assume that other sources (e.g. dietary, residential) than AFFF are more 
important for PFNA exposure at background level. 
Our baseline data for the Ronneby Biomarker Cohort showed that the 
serum PFAS levels decreased from early age through preteen to ten ages, 
with lowest levels at age 11–20 in both sexes, which is likely explained 
by the expansion of body volume as the child grows. After age 20, serum 
PFAS levels increased with age. Before age 60, females showed lower 
serum levels of all PFAS than males. The largest sex difference was seen 
in the age range 20–50, explained by PFAS elimination through 
menstruation, pregnancy and breast feeding (Li et al., 2018; Wong et al., 
2014). The contrast in serum PFAS levels between men and women 
became smaller in 51–60 years old. Women had higher levels than men 
from 60 years and up, though these differences did not reach statistical 
significance. In the C8 study, a similar pattern was evident for women, 
with higher PFOA than men after around 65 years old, but not for PFOS 
and PFHxS (Frisbee et al., 2009). In another Swedish study including 
subjects aged 70 and above, with overall much lower serum levels, 
higher PFHxS in women than in men was reported, but no sex-difference 
for PFOA and PFOS (Salihovic et al., 2015). The underlying physiolog-
ical mechanisms are not known, and the possibility of higher de-
pendency on residential drinking water in women has not been ruled 
out. Additionally, it should be noted that these observations were based 
on cross-sectional, not longitudinal data. 
External exposure assessment as a complement to direct measure-
ment is important in cross-sectional studies, to help in identifying 
possible confounding or reverse causation (Weisskopf and Webster, 
2017). Unfortunately, no water data before 2013 on PFAS in drinking 
water is available, therefore a relative crude exposure modelling based 
on yearly addresses and water distribution data was used to reflect the 
contamination accumulating over time (Andersson et al., 2019; Xu et al., 
2020a),. The large contrast in serum levels in 2014 between the early- 
high and late-high groups reflects both excretion after stopping expo-
sure (following the long half-lives) and assumed lower water concen-
trations in the past. 
When the drinking water contamination was discovered in Ronneby 
in 2013, 6:2, and 8:2 fluorotelomer sulfonate (FTS) were not included in 
the water and serum analysis. These two compounds were observed at 
AFFF firefighter training areas after the shift from electrochemical 
fluorination to telomerization method for production (Schultz et al., 
2004, Houtz et al., 2013, Buck et al., 2011). Future studies are needed to 
investigate serum levels of these compounds in the populations exposed 
to AFFF-related contamination. 
The long half-life of PFAS that dominated in the Ronneby population 
indicates a large body burden of PFAS in the exposed population that 
will remain for decades (Li et al., 2018). Considering the large variation 
in PFAS elimination rate between persons, if an 11-years-old child who 
had been exposed to PFAS through drinking water and had PFHxS level 
as 270 ng/mL (the median level in Table S1), it will take him/her from 
30 to 70 years to reach a level as 5 ng/mL, the median level found in the 
same age child without PFAS exposure in drinking water. During these 
years, although the external exposure has stopped, the body burden 
remains and may cause adverse health effects. More importantly, these 
years with internal exposure are also a problem for next one or even two 
generations since PFAS pass from mother to infant throughout preg-
nancy and breastfeeding (Mamsen et al., 2019; Mogensen et al., 2015; 
Mondal et al., 2014). In order to elucidate potential health effects in the 
Ronneby residents, an extensive research program with multiple 
ongoing studies has been established (Figure S1). The findings are 
Table 8 























Never-high 582 30 2.9 204 29 (25, 
33) 
1  
Reference 226 0.84 0.33 3.5 1 – 















Reference 226 3.9 1.6 11 1 – 



































Reference 226 6.6 3 17 1 – 
Note: PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonic acid; 
PFOS, perfluorooctane sulfonic acid, PFOA, perfluorooctanoic acid; GM: geo-
metric mean; P5, P95: 5 and 95 percentiles. 
a Detailed definition of groups see Table 4. 
b Ratio and 95% CI were obtained from regression model: ln_PFAS = a +
β1*exposure groups + β2*sex + β3*BMI + β4*age. Age and BMI were treated as 
smooth functions (thin plate splines) in the model. The ratio = exp (β1). 
c Comparison was late-high/early-high/never-high groups vs. Reference. For 
instance: Late-high group had average 193 times higher PFHxS than the refer-
ence group. 
d Comparison was late-high/early-high groups vs. Never-high group. For 
instance: Late-high group had average 6.8 times higher PFHxS than the never- 
high group. 
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important for further regulatory actions for the large class of PFAS. 
5. Conclusion 
The PFAS contamination in drinking water which occurred in Ron-
neby resulted in up to hundredfold or even higher serum levels than in a 
population with only background exposure. Contamination of drinking 
water with PFAS is not unique, but the very high serum levels in com-
bination with a wide range, especially for PFHxS and PFOS, hitherto not 
reported from any other general population, enables in-depth studies of 
dose-response and dose-effect relationships. Ongoing studies have the 
potential to improve the current understanding of the biology of PFAS 
exposure and therefore inform future regulation to protect populations 
exposed to PFAS. 
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Magdalena Lewandowski, Martin Önnerfors, Kirk Scott, Anna Rignell- 
Hydbom, Charlotte Stübner, Carmela Miniscalco Mattsson, Anna Lars-
son and Estelle Larsson, for their inputs in the Program. The study was 
initiated by the department of Occupational and Environmental Medi-
cine, Scania University Hospital, with additional funding from the 
Swedish Research Councils FORMAS and FORTE. 
Appendix A. Supplementary material 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.envint.2020.106333. 
References 
Andersson, E.M., Scott, K., Xu, Y., Li, Y., Olsson, D.S., Fletcher, T., et al., 2019. High 
exposure to perfluorinated compounds in drinking water and thyroid disease. A 
cohort study from Ronneby, Sweden. Environ. Res. 176 (108540) https://doi.org/ 
10.1016/j.envres.2019.108540. 
Barton, K.E., Starling, A.P., Higgins, C.P., McDonough, C.A., Calafat, A.M., Adgate, J.L., 
2020. Sociodemographic and behavioral determinants of serum concentrations of 
per- and polyfluoroalkyl substances in a community highly exposed to aqueous film- 
forming foam contaminants in drinking water. Int. J. Hyg. Environ. Health 223 (1), 
256–266. https://doi.org/10.1016/j.ijheh.2019.07.012. 
Begley, T.H., White, K., Honigfort, P., Twaroski, M.L., Neches, R., Walker, R.A., 2005. 
Perfluorochemicals: Potential sources of and migration from food packaging. Food 
Addit. Contam. 22, 1023–1031. https://doi.org/10.1080/02652030500183474. 
Berger, U., Glynn, A., Holmström, K.E., Berglund, M., Ankarberg, E.H., Törnkvist, A., 
2009. Fish consumption as a source of human exposure to perfluorinated alkyl 
substances in sweden - analysis of edible fish from lake vättern and the baltic sea. 
Chemosphere 76, 799–804. https://doi.org/10.1016/j.chemosphere.2009.04.044. 
Buck, R.C., Franklin, J., Berger, U., Conder, J.M., Cousins, I.T., De Voogt, P., et al., 2011. 
Perfluoroalkyl and polyfluoroalkyl substances in the environment: Terminology, 
classification, and origins. Integr. Environ. Assess. Manage. 7, 513–541. https://doi. 
org/10.1002/ieam.258. 
CDC, 2018. CDC National report on human exposure to environmental chemicals. 
Available at: https://www.cdc.gov/exposurereport/index.html (2018). Accessed on 
October 16, 2020. 
Daly, E.R., Chan, B.P., Talbot, E.A., et al., 2018. Per- and polyfluoroalkyl substance 
(PFAS) exposure assessment in a community exposed to contaminated drinking 
water, New Hampshire, 2015. Int. J. Hyg. Environ. Health 221 (3), 569–577. 
https://doi.org/10.1016/j.ijheh.2018.02.007. 
Table 9 
Summary of PFAS levels in the present study and in other studies referred in the discussion.  
Cohort Area PFAS origin PFHxS (ng/mL) PFOS (ng/mL) PFOA (ng/mL) ref 
PFAS exposure through drinking water 
Ronneby Biomarker 
Cohort 
Ronneby, Sweden AFFF firefighting foam GM: 114 135 6.8 Present study 
C8 West Virginia, US DuPont Industry GM: 3.3 19 33 Frisbee et al. (2009) 
Veneto Veneto Region, 
Italy 
Chemical plant producing 
herbicides 
Median: 3.0 8.7 14 Ingelido et al. (2018) 









Hölzer et al. (2008) 
Uppsala Uppsala. Sweden AFFF Median: 1.8 18 2.6 Gyllenhammar et al. 
(2015) 
New Hampshire New Hampshire, 
US 
AFFF GM: 4.1 3.1 8.6 Daly et al. (2018) 
Colorado Colorado, US AFFF Median: 14.8 9.7 3.0 Barton et al. (2020) 
Pennsylvania Pennsylvania, US AFFF GM: 6.6 10.2 3.1 Nair et al. (2020) 
Background PFAS exposure 







NHANES (2015–2016) US   
Median: 1.2 

















EFSA (2020)  
Y. Xu et al.                                                                                                                                                                                                                                       
Environment International 147 (2021) 106333
10
Domingo, J.L., Nadal, M., 2019. Human exposure to per- and polyfluoroalkyl substances 
(PFAS) through drinking water: A review of the recent scientific literature. Environ. 
Res. 177, 108648 https://doi.org/10.1016/j.envres.2019.108648. 
Drinking Water Commission of the German Ministry of Health at the Federal 
Environment Agency. 2006. Provisional evaluation of PFT in drinking water with the 
guide substances perfluorooctanoid acid (PFOA) and perfluorooctane sulfonate 
(PFOS) as examples. Available from https://www.umweltbundesamt.de/sites/ 
default/files/medien/pdfs/pft-in-drinking-water.pdf. Accessed on 2020-06-03. 
EFSA, 2020. Risk to human health related to the presence of perfluoroalkyl substances in 
food. EFSA J. 8(9), e06223. https://doi.org/10.2903/j.efsa.2020.6223. 
Falandysz, J., Taniyasu, S., Gulkowska, A., Yamashita, N., Schulte-Oehlmann, U., 2006. 
Is fish a major source of fluorinated surfactants and repellents in humans living on 
the baltic coast? Environ. Sci. Technol. 40, 748–751. https://doi.org/10.1021/ 
es051799n. 
Frisbee, S.J., Brooks Jr, A.P., Maher, A., Flensborg, P., Arnold, S., Fletcher, T., et al., 
2009. The C8 health project: design, methods, and participants. Environ. Health 
Perspect. 117, 1873–1882. https://doi.org/10.1289/ehp.0800379. 
Glynn, A., Kotova, N., Dahlgren, E., Lindh, C., Jakobsson, K., Gyllenhammar, I., et al., 
2020. Determinants of serum concentrations of perfluoroalkyl acids (PFAAs) in 
school children and the contribution of low-level pfaa-contaminated drinking water. 
Environ. Sci. Process Impacts 22, 930–944. https://doi.org/10.1039/c9em00497a. 
Gyllenhammar, I., Berger, U., Sundström, M., et al., 2015. Influence of contaminated 
drinking water on perfluoroalkyl acid levels in human serum–a case study from 
Uppsala, Sweden. Environ. Res. 140, 673–683. https://doi.org/10.1016/j. 
envres.2015.05.019. 
Houde, M., Martin, J.W., Letcher, R.J., Solomon, K.R., Muir, D.C., 2006. Biological 
monitoring of polyfluoroalkyl substances: A review. Environ. Sci. Technol. 40, 
3463–3473. https://doi.org/10.1021/es052580b. 
Houtz, E.F., Higgins, C.P., Field, J.A., Sedlak, D.L., 2013. Persistence of perfluoroalkyl 
acid precursors in AFFF-impacted groundwater and soil. Environ Sci Technol 47 
(15). https://doi.org/10.1021/es4018877. 
Hölzer, J., Midasch, O., Rauchfuss, K., Kraft, M., Reupert, R., Angerer, J., et al., 2008. 
Biomonitoring of perfluorinated compounds in children and adults exposed to 
perfluorooctanoate-contaminated drinking water. Environ. Health Perspect. 116, 
651–657. https://doi.org/10.1289/ehp.11064. 
Ingelido, A.M., Abballe, A., Gemma, S., Dellatte, E., Iacovella, N., De Angelis, G., et al., 
2018. Biomonitoring of perfluorinated compounds in adults exposed to 
contaminated drinking water in the Veneto region, Italy. Environ. Int. 110, 149–159. 
https://doi.org/10.1016/j.envint.2017.10.026. 
Jakobsson, K., Georgellis, A., Lilja, K., Norström, K., Nilsson, C., Pineda, D., Lindh, C.H., 
2019. Serum levels of a range of perfluorinated substances (PFAS) after drinking 
water exposure in three populations living around military and civil airfields in 
Sweden. Environ. Epidemi. 3. October 2019 - 10.1097/01. 
EE9.0000607764.32607.01 (Conference abstract).  
Kwiatkowski, C.F., et al., 2020. Scientific basis for managing PFAS as a chemical class. 
Environ. Sci. Technol. Lett. 7 (8), 532–543. https://doi.org/10.1021/acs. 
estlett.0c00255. 
Li, Y., Fletcher, T., Mucs, D., Scott, K., Lindh, C.H., Tallving, P., et al., 2018. Half-lives of 
pfos, pfhxs and pfoa after end of exposure to contaminated drinking water. Occup. 
Environ. Med. 75, 46–51. https://doi.org/10.1136/oemed-2017-104651. 
Lindh, C.H., Rylander, L., Toft, G., Axmon, A., Rignell-Hydbom, A., Giwercman, A., et al., 
2012. Blood serum concentrations of perfluorinated compounds in men from 
greenlandic inuit and European populations. Chemosphere 88, 1269–1275. https:// 
doi.org/10.1016/j.chemosphere.2012.03.049. 
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